COCP Cocrystal Pharma Forecast, Technical & Fundamental Analysis
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses... Show more
COCP is expected to report earnings to fall 2.94% to -16 cents per share on August 17
Q2'26
Est.
$-0.17
Q1'26
Beat
by $0.09
Q4'25
Beat
by $0.12
Q3'25
Beat
by $0.15
Q2'25
Beat
by $0.17
The last earnings report on May 15 showed earnings per share of -17 cents, beating the estimate of -25 cents. With 74.32K shares outstanding, the current market capitalization sits at 13.72M.
A.I. Advisor
published General Information
General Information
a developer of novel medicines for use in the treatment of human viral diseases
A.I.dvisor tells us that COCP and VKTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COCP and VKTX's prices will move in lockstep.
COCP's RSI Indicator recovers from oversold territory
The RSI Oscillator for COCP moved out of oversold territory on June 17, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In of the 31 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for COCP just turned positive on June 18, 2026. Looking at past instances where COCP's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COCP advanced for three days, in of 190 cases, the price rose further within the following month. The odds of a continued upward trend are .
COCP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
COCP moved below its 50-day moving average on May 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for COCP crossed bearishly below the 50-day moving average on May 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COCP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for COCP entered a downward trend on June 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. COCP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.333) is normal, around the industry mean (20.056). P/E Ratio (0.000) is within average values for comparable stocks, (35.868). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.677). COCP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (54.054) is also within normal values, averaging (361.304).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COCP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
